VRNA

65.97

5.26% -3.66

Handel nachbörslich: 66.04 0.07 +0.11%

Verona Pharma Plc Adr (VRNA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$69.63

Offen:

$69.85

24-Stunden-Volumen:

1.35M

Relative Volume:

1.05

Marktkapitalisierung:

$5.88B

Einnahmen:

Nettoeinkommen (Verlust:

$-153.72M

KGV:

-32.98

EPS:

-2

Netto-Cashflow:

$-103.81M

1W Leistung:

+0.56%

1M Leistung:

+11.85%

6M Leistung:

+142.45%

1J Leistung:

+262.67%

1-Tages-Spanne:

$65.63

$70.40

1-Wochen-Bereich:

$62.22

$70.40

52-Wochen-Spanne:

$11.39

$70.40

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Firmenname

Verona Pharma Plc Adr

Sektor

Healthcare (1189)

Branche

Biotechnology (682)

Telefon

011-44-0-2032834200

Adresse

3 MORE LONDON RIVERSIDE, LONDON

Mitarbeiter

Twitter

@VeronaPharma

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

VRNA's Discussions on Twitter

Vergleichen Sie VRNA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VRNA Verona Pharma Plc Adr	65.97	5.88B	0	-153.72M	-103.81M	-2.00
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-10	Eingeleitet	ROTH MKM	Buy
2024-10-03	Eingeleitet	Wells Fargo	Overweight
2023-05-22	Fortgesetzt	Jefferies	Buy
2022-09-19	Fortgesetzt	Wedbush	Outperform
2022-08-26	Eingeleitet	Piper Sandler	Overweight
2021-09-13	Eingeleitet	H.C. Wainwright	Buy
2020-08-25	Eingeleitet	Jefferies	Buy
2020-08-10	Eingeleitet	Canaccord Genuity	Buy
2019-04-18	Eingeleitet	BTIG Research	Buy

Alle ansehen

Verona Pharma Plc Adr Aktie (VRNA) Neueste Nachrichten

Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada

Feb 27, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com

Feb 27, 2025

Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK

Feb 27, 2025

Feb 21, 2025

A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily

Feb 21, 2025

Feb 13, 2025

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - GlobeNewswire Inc.

Feb 13, 2025

Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 - Investing.com India

Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa

Feb 12, 2025

Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa

Feb 12, 2025

Feb 11, 2025

Investor’s Delight: Lithium Americas Corp (NewCo) (LAC) Closes Weak at 2.97, Down -1.98 - The Dwinnex

Feb 11, 2025

There is no doubt that Verona Pharma Plc ADR (VRNA) ticks all the boxes. - SETE News

Feb 11, 2025

Analyzing Verona Pharma Plc ADR (VRNA) After Recent Trading Activity - Knox Daily

Feb 11, 2025

Rumble Inc (RUM)’s Market Momentum: Closing Strong at 12.25, Down -3.92 - The Dwinnex

Feb 11, 2025

Market Recap Check: Lineage Cell Therapeutics Inc (LCTX)’s Negative Finish at 0.66, Up/Down -2.12 - The Dwinnex

Feb 11, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: OrganiGram Holdings Inc (OGI) - SETE News

Feb 11, 2025

Feb 06, 2025

Are Smart Investors Making the Right Decision? Verona Pharma Plc ADR (VRNA) - SETE News

Feb 06, 2025

Healthy Upside Potential: Solidion Technology Inc (STI) - SETE News

Feb 06, 2025

Feb 05, 2025

Stock Surge: XPO Inc (XPO) Closes at 131.50, Marking a 2.24 Increase/Decrease - The Dwinnex

Feb 05, 2025

Closing Figures Unveiled: Diageo plc ADR (DEO) Drop -0.84, Closes at 115.95 - The Dwinnex

Feb 05, 2025

Market Watch Highlights: Verona Pharma Plc ADR (VRNA) Ends on an Upturn Note at 59.94 - The Dwinnex

Feb 05, 2025

Market Momentum Report: Lemonade Inc (LMND)’s Positive Close at 33.99 - The Dwinnex

Feb 05, 2025

Checking in on Verona Pharma Plc ADR (VRNA) after recent insiders movement - Knox Daily

Feb 04, 2025

A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News

Feb 04, 2025

Have you been able to find a good deal on Verona Pharma Plc ADR’s shares? - US Post News

Feb 04, 2025

The Agilon Health Inc (AGL) had a good session last reading, didn’t it? - US Post News

Feb 04, 2025

How should investors view Relay Therapeutics Inc (RLAY)? - US Post News

Feb 04, 2025

Jan 21, 2025

Verona Pharma stock target upgraded, retains buy on Q4 results By Investing.com - Investing.com South Africa

Jan 21, 2025

Jan 17, 2025

Looking For A Top Momentum Pick? Why Valley National Bancorp (NASDAQ: VLY) Is A Great Choice - Stocks Register

Jan 17, 2025

Hertz Global Holdings Inc (NASDAQ: HTZ): Overvalued Compared To Others? - Stocks Register

Jan 17, 2025